Premier Path Wealth Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$783K Sell
9,078
-2,685
-23% -$237K 0.09% 200
2026
Q2
$920K Sell
11,763
-4,292
-27% -$346K 0.11% 183
2026
Q1
$1.39M Sell
16,055
-549
-3% -$52.6K 0.18% 127
2025
Q4
$1.6M Sell
16,604
-1,132
-6% -$110K 0.21% 102
2025
Q3
$1.69M Sell
17,736
-15
-0.1% -$1.38K 0.22% 99
2025
Q2
$1.55M Buy
17,751
+192
+1% +$16.3K 0.22% 109
2025
Q1
$1.58M Buy
17,559
+47
+0.3% +$4.21K 0.25% 97
2024
Q4
$1.4M Sell
17,512
-12
-0.1% -$1.04K 0.21% 104
2024
Q3
$1.58M Buy
17,524
+389
+2% +$32.7K 0.25% 96
2024
Q2
$1.35M Buy
17,135
+579
+3% +$47.5K 0.23% 105
2024
Q1
$1.43M Buy
16,556
+2,817
+21% +$240K 0.27% 93
2023
Q4
$1.14M Buy
+13,739
New +$1.05M 0.25% 99

Other funds holding MDT

Premier Path Wealth Partners's MDT Position: Q3 2026 in Review

Premier Path Wealth Partners reduced its Medtronic (MDT) stake by 23% in Q3 2026, selling an estimated $237K and leaving 9,078 shares worth $783K. The position accounts for 0.09% of the portfolio, ranked #200.

Premier Path Wealth Partners first reported a position in MDT in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.69M in Q3 2025. 478 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Premier Path Wealth Partners held 9,078 shares of Medtronic worth $783K as of Q3 2026.
  • Premier Path Wealth Partners sold 2,685 Medtronic shares in Q3 2026, an estimated $237K.
  • Medtronic made up 0.09% of Premier Path Wealth Partners's portfolio in Q3 2026, its #200 holding.
  • Premier Path Wealth Partners first reported a position in Medtronic in Q4 2023 and has held it in 12 quarters since.
  • Premier Path Wealth Partners's Medtronic position peaked at $1.69M in Q3 2025.
  • 478 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Premier Path Wealth Partners's 13F filing for Q3 2026, filed 16 Oct 2026.